<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04459182</url>
  </required_header>
  <id_info>
    <org_study_id>2020-A01855-34</org_study_id>
    <nct_id>NCT04459182</nct_id>
  </id_info>
  <brief_title>Circulating Exosomes and Endothelial Dysfunction in Patients With Obstructive Sleep Apneas Hypopneas Syndrome</brief_title>
  <acronym>EXODYS</acronym>
  <official_title>Circulating Exosomes and Endothelial Dysfunction in Patients With Obstructive Sleep Apneas Hypopneas Syndrome(OSA): EXODYS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of miRNA contained in exosomes in obese and OSA patients with endothelial
      dysfunction evaluated by digital plethysmography (ENDOPAT) compared to obese and OSA patients
      without endothelial dysfunction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to compare the content of exosomes between two goups of 20 patients,
      with and without endothelial dysfucntion.

      the endothelial function will be evaluated after polysomnography, on obese patients with OSA
      (AHI &gt;15).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>miRNA cointained in exosomes</measure>
    <time_frame>immediately after the consultation</time_frame>
    <description>compare exosome content between obese-OSA patients with endothelial dysfunction and without</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Endothelial Dysfunction</condition>
  <arm_group>
    <arm_group_label>Endothelial dysfunction (DE+)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>obsese patient with OSA (AHI&gt;15) and endothelial dysfunction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No endothelial dysfunction (DE-)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>obsese patient with OSA (AHI&gt;15) and no endothelial dysfunction</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>ENDOPAT</intervention_name>
    <description>digital plethysmography</description>
    <arm_group_label>Endothelial dysfunction (DE+)</arm_group_label>
    <arm_group_label>No endothelial dysfunction (DE-)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult subject

          -  Subject understands the study protocol and is willing and able to comply with study
             requirements and sign informed consent

          -  Subject with OSA (defined by AHI &gt;15/h)

        Exclusion Criteria:

          -  cardiac or vascular desease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>GAGNADOUX Frédéric, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Angers</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>GAGNADOUX Frédéric, PhD</last_name>
    <phone>+33241353695</phone>
    <email>frgagnadoux@chu-angers.fr</email>
  </overall_contact>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 30, 2020</study_first_submitted>
  <study_first_submitted_qc>July 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 7, 2020</study_first_posted>
  <last_update_submitted>July 3, 2020</last_update_submitted>
  <last_update_submitted_qc>July 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

